Related Experiment Video
Updated: Jun 10, 2026

Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers
Published on: July 21, 2017
Capped mesoporous silica nanoparticles as stimuli-responsive controlled release systems for intracellular drug/gene
Yannan Zhao1, Juan L Vivero-Escoto, Igor I Slowing
1Iowa State University, Department of Chemistry, US Department of Energy Ames Laboratory, Ames, IA 50011-3111, USA.
Importance Of The Field:
The incorporation of stimuli-responsive properties into nanostructured systems has recently attracted significant attention in the research of intracellular drug/gene delivery. In particular, numerous surface-functionalized, end-capped mesoporous silica nanoparticle (MSN) materials have been designed as efficient stimuli-responsive controlled release systems with the advantageous 'zero premature release' property.
Areas Covered In This Review:
Herein, the most recent research progress on the design of biocompatible, capped MSN materials for stimuli-responsive intracellular controlled release of therapeutics and genes is reviewed. A series of hard and soft caps for drug encapsulation and a variety of internal and external stimuli for controlled release of different cargoes are summarized. Recent investigations on the biocompatibility of MSN both in vitro and in vivo are also discussed.
What The Reader Will Gain:
The reader will gain an understanding of the challenges for the future exploration of biocompatible stimuli-responsive MSN devices.
Take Home Message:
With a better understanding of the unique features of capped MSN and its behaviors in biological environment, these multifunctional materials will find a wide variety of applications in the field of drug/gene delivery.
Related Concept Videos
Modified-Release Drug Delivery Systems: Stimuli-Activated
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Classification
Modified-Release Drug Delivery Systems: Rate-Programmed II
Modified-Release Drug Delivery Systems: Site-Targeted
Modified-Release Drug Delivery Systems: Rate-Programmed I

